Extended Data Fig. 9: Primary explants from residual S-Gboxin-treated tumours retain Gboxin/S-Gboxin sensitivity in culture.
From: Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
a, b, Cell viability assays show primary tumour cultures from tumours treated with vehicle control (a) or S-Gboxin (b), as in Fig. 6a. Mean ± s.d., n = 3. Residual tumour cells treated with S-Gboxin remain sensitive to Gboxin and S-Gboxin, and have a blunted mPTP response.
